Boston Financial Management’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-5,695
Closed -$262K 286
2016
Q3
$262K Sell
5,695
-4,016
-41% -$185K 0.02% 225
2016
Q2
$488K Sell
9,711
-2,560
-21% -$129K 0.04% 194
2016
Q1
$657K Sell
12,271
-275
-2% -$14.7K 0.1% 131
2015
Q4
$824K Sell
12,546
-9,770
-44% -$642K 0.12% 129
2015
Q3
$1.26M Sell
22,316
-11,590
-34% -$654K 0.18% 124
2015
Q2
$2M Sell
33,906
-585
-2% -$34.6K 0.26% 112
2015
Q1
$2.15M Sell
34,491
-30
-0.1% -$1.87K 0.27% 105
2014
Q4
$1.99M Buy
34,521
+7,455
+28% +$429K 0.25% 110
2014
Q3
$1.46M Buy
27,066
+760
+3% +$40.9K 0.19% 126
2014
Q2
$1.38M Buy
26,306
+7,375
+39% +$387K 0.18% 131
2014
Q1
$1M Buy
18,931
+4,825
+34% +$255K 0.13% 145
2013
Q4
$565K Sell
14,106
-2,245
-14% -$89.9K 0.08% 156
2013
Q3
$618K Sell
16,351
-3,135
-16% -$118K 0.09% 150
2013
Q2
$764K Buy
+19,486
New +$764K 0.12% 143